These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19557837)

  • 41. Generation of chromosomal DNA during alkaline lysis and removal by reverse micellar extraction.
    Tschapalda K; Streitner N; Voss C; Flaschel E
    Appl Microbiol Biotechnol; 2009 Aug; 84(1):199-204. PubMed ID: 19562335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Purification of plasmid DNA by chromatographic methods].
    Naumov GN
    Mol Gen Mikrobiol Virusol; 1985 Sep; (9):44-7. PubMed ID: 3916234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mycobacteriophage Ms6 encodes a chaperone-like protein involved in the endolysin delivery to the peptidoglycan.
    Catalão MJ; Gil F; Moniz-Pereira J; Pimentel M
    Mol Microbiol; 2010 Aug; 77(3):672-86. PubMed ID: 20545844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
    Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
    Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A chromatographic method for determination of supercoiled plasmid DNA concentration in complex solutions.
    Bennemo M; Blom H; Emilsson A; Lemmens R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2530-6. PubMed ID: 19616488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integration of bacteria capture via filtration and in situ lysis for recovery of plasmid DNA under industry-compatible conditions.
    O'Mahony K; Freitag R; Hilbrig F; Schumacher I; Müller P
    Biotechnol Prog; 2007; 23(4):895-903. PubMed ID: 17628077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Holin protein of bacteriophage PRD1 forms a pore for small-molecule and endolysin translocation.
    Ziedaite G; Daugelavicius R; Bamford JK; Bamford DH
    J Bacteriol; 2005 Aug; 187(15):5397-405. PubMed ID: 16030234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a highly productive and scalable plasmid DNA production platform.
    Listner K; Bentley L; Okonkowski J; Kistler C; Wnek R; Caparoni A; Junker B; Robinson D; Salmon P; Chartrain M
    Biotechnol Prog; 2006; 22(5):1335-45. PubMed ID: 17022672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pilot-scale production of recombinant plasmid pUDK-HGF].
    Hu C; Wang Y; Lu Y; Cheng X; Liu L; Zhang T; Zhang Q
    Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):247-52. PubMed ID: 21650050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large-scale, nonchromatographic purification of plasmid DNA.
    Murphy JC; Winters MA; Sagar SL
    Methods Mol Med; 2006; 127():351-62. PubMed ID: 16988465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy.
    Mairhofer J; Pfaffenzeller I; Merz D; Grabherr R
    Biotechnol J; 2008 Jan; 3(1):83-9. PubMed ID: 17806101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography.
    Sousa F; Prazeres DM; Queiroz JA
    J Gene Med; 2009 Jan; 11(1):79-88. PubMed ID: 19021136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mass balance study to assess the extent of contaminant removal achieved in the operations for the primary recovery of plasmid DNA from Escherichia coli cells.
    Ciccolini LA; Shamlou PA; Titchener-Hooker N
    Biotechnol Bioeng; 2002 Mar; 77(7):796-805. PubMed ID: 11835140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid quantitation and monitoring of plasmid DNA using an ultrasensitive DNA-binding dye.
    Noites IS; O'Kennedy RD; Levy MS; Abidi N; Keshavarz-Moore E
    Biotechnol Bioeng; 1999; 66(3):195-201. PubMed ID: 10577474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine.
    Okonkowski J; Kizer-Bentley L; Listner K; Robinson D; Chartrain M
    Biotechnol Prog; 2005; 21(4):1038-47. PubMed ID: 16080681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production of fuculose-1-phosphate aldolase using operator-repressor titration for plasmid maintenance in high cell density Escherichia coli fermentations.
    Durany O; Bassett P; Weiss AM; Cranenburgh RM; Ferrer P; López-Santín J; de Mas C; Hanak JA
    Biotechnol Bioeng; 2005 Aug; 91(4):460-7. PubMed ID: 15959893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-level expression and bulk crystallization of recombinant L-methionine gamma-lyase, an anticancer agent.
    Takakura T; Ito T; Yagi S; Notsu Y; Itakura T; Nakamura T; Inagaki K; Esaki N; Hoffman RM; Takimoto A
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):183-92. PubMed ID: 16012835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential CaCl2, polyethylene glycol precipitation for RNase-free plasmid DNA isolation.
    Sauer ML; Kollars B; Geraets R; Sutton F
    Anal Biochem; 2008 Sep; 380(2):310-4. PubMed ID: 18571491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system.
    Pfaffenzeller I; Mairhofer J; Striedner G; Bayer K; Grabherr R
    Biotechnol J; 2006 Jun; 1(6):675-81. PubMed ID: 16892316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.